Michelle Seitz - Jun 8, 2023 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
Director
Signature
/s/ Bernard J. Cassidy, Attorney-in-Fact for Michelle Seitz
Stock symbol
SANA
Transactions as of
Jun 8, 2023
Transactions value $
$0
Form type
4
Date filed
6/9/2023, 04:34 PM
Previous filing
Jun 8, 2022
Next filing
Jun 7, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SANA Stock Option (Right to Buy) Award $0 +65K $0.00 65K Jun 8, 2023 Common Stock 65K $6.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 8, 2024 and (ii) immediately prior to Sana Biotechnology, Inc.'s next annual meeting of stockholders following June 8, 2023.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney